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ABSTRACT
Moyamoya syndrome (MMS) is a rare, chronic and progressive vasculopathy with a characteristic angiographic pattern and well-recognized 
predisposing conditions, such as cranial therapeutic radiation. We report the case of a 36-year-old Caucasian female with a history of 
craniopharyngioma treated with whole-brain radiotherapy 20 years previously. She was admitted to the emergency department with 
disorientation and imperceptible speech lasting for 1 hour. Upon examination, she had slight motor aphasia, without sensory or motor 
deficits. However, the neurological deficits worsened on standing position. The computed tomography (CT) angiogram and transcranial 
Doppler ultrasonography revealed occlusion of the distal portion of the left internal carotid artery (ICA). Mechanical thrombectomy 
was attempted without success. Head CT was repeated, revealing left periventricular acute ischaemic stroke. The cerebral angiography 
showed total occlusion of the left ICA with an exuberant network of transdural collateral vessels, confirming MMS. The patient completed a 
functional rehabilitation program with progressive improvement of deficits and maintained a multidisciplinary follow-up. MMS is a serious 
late complication from cranial radiation therapy and a well-described risk factor for ischaemic stroke in younger patients. Therefore, early 
detection and prompt treatment are mandatory, as the consequences can be disastrous, such as cognitive and neurologic decline due to 
repeated strokes.
LEARNING POINTS
• Moyamoya syndrome should be considered in younger patients presenting with acute neurologic deficits, particularly those treated 
with cranial radiotherapy. 
• The treatment of acute stroke in patients with moyamoya syndrome should include intravenous hydration and avoidance of hypotension. 
• The benefit of antiplatelet agents is limited and equivocal for patients with moyamoya syndrome and oral anticoagulants are not 
recommended for long-term treatment. 
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CASE DESCRIPTION 
We report the case of a Caucasian female with a history of craniopharyngioma at the age of 16, treated with surgery and adjuvant whole-brain 
radiotherapy. Despite a good outcome without signs of relapse, there were some sequelae, including panhypopituitarism, severe bilateral 
hypovision, right hearing loss and developmental delay with limited functional status (modified Rankin scale score of 3/6). She presented at 
our emergency department at the age of 36 with disorientation and imperceptible speech lasting for 1 hour. Upon examination, she had slight 
motor aphasia, scoring 2 on the National Institutes of Health Stroke Scale (NIHSS). Laboratory studies revealed no changes. Non-contrast 
computed tomography (CT) of the head revealed no acute ischaemic lesions or intracerebral haemorrhage. Neurological deficits worsened 
after approximately 2 to 3 minutes of standing up, with left-sided hemiparesis, mild left sensory loss and dysarthria (NIHSS score of 6). The 
neurological deficits improved after lying down. A CT angiogram revealed occlusion of the distal portion of the left internal carotid artery 
(ICA) up to the proximal segments of the ipsilateral middle (MCA) and anterior (ACA) cerebral arteries, as well as diffuse reduction in the 
calibre of the right ICA, more markedly in the intracranial portion. Transcranial Doppler ultrasonography (TCD) confirmed occlusion of the 
distal portion of the left ICA and showed signs of collateralization to the right carotid territory via the ipsilateral posterior communicating 
artery (Fig. 1). Mechanical thrombectomy was attempted without success since the guidewire could not go through the left ICA after the 
emergence of the ophthalmic artery. 
Figure 1. Transcranial Doppler ultrasonography showed occlusion of 
the distal portion of the left internal carotid artery
Mechanical thrombectomy was attempted without success since the guidewire could not go through the left ICA after the emergence of the 
ophthalmic artery. 
The patient was admitted to the Stroke Unit. Control head CT revealed acute left periventricular ischaemic stroke. An echocardiogram, 
continuous heart rate monitoring and extensive laboratory studies were unrevealing. Cerebral angiography was performed and confirmed 
the findings of total occlusion of the left ICA with multiple leptomeningeal collateral vessels of the left posterior cerebral artery filling 
retrogradely the territory of the left MCA (Fig. 2). Furthermore, cerebral angiography revealed right ICA occlusion after the emergence 
of the anterior choroidal artery and an abnormal network of transdural collateral vessels that filled retrogradely the territory of the right 
MCA and ACA (Fig. 3). These angiographic findings are characteristic of bilateral moyamoya syndrome (MMS). The patient was started on 
platelet antiaggregation treatment and a statin. During her hospital stay, she completed a functional rehabilitation program with progressive 
improvement of deficits. She was discharged with an NIHSS score of 3. The patient maintained a multidisciplinary follow-up (Physiatry, 
Neurology and Neurosurgery), and revascularization surgery is being considered. 
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DISCUSSION
Moyamoya disease (MMD) is a rare, chronic and progressive vasculopathy characterized by stenosis or occlusion of the intracranial ICA 
and the proximal branches[1]. Despite familial occurrence in approximately 10–15% of cases, the aetiology of MMD remains unknown[2]. 
The Japanese term “moyamoya” means “puff of smoke” and is a reference to the pathognomonic arteriographic appearance of MMD, 
corresponding to compensatory development of prominent arterial collateral circulation[3]. Traditionally, patients with these characteristic 
features and no known associated risk factors are considered to have MMD, while those having one of the well-recognized predisposing 
conditions are classified as having MMS[4]. There are numerous reported links between MMS and a wide variety of diseases, the most 
frequent and strongly associated conditions being neuro-fibromatosis type 1, cranial therapeutic radiation, Down syndrome and sickle cell 
disease[2, 4]. 
Radiation-induced MMS is a serious, well-described and probably frequent, yet under-recognized, late complication of cranial radiotherapy[3]. 
A younger age at radiation exposure seems to increase the risk of developing vasculopathy, with over half of all cases occurring in children 
under 5 years of age[3, 5]. Not surprisingly, a parasellar tumour location, such as with craniopharyngiomas, is another risk factor, likely due to 
the close relationship to the circle of Willis of the tumour[2–5]. To prevent it, some authors suggest reduced radiation doses in children with 
parasellar tumours[5]. However, the amount of energy necessary to cause this effect is unknown[1], and the latency between radiation and 
vasculopathy development may vary from several months to years[4]. 
Generically, the symptoms may be due to brain ischaemia related to the hypoperfused hemisphere or to the deleterious consequences of 
the compensatory mechanisms responding to the ischaemia[1]. If, on the one hand, the rate of haemorrhage among adults is approximately 7 
times higher than the rate among children[1], on the other, MMS accounts for as much as 6% of childhood strokes[3, 4]. Thus, MMS should be 
considered in younger patients presenting with acute neurologic deficits, particularly those treated with cranial radiotherapy. 
Figure 2. Cerebral angiography showed total occlusion of 
the left internal carotid artery with multiple leptomeningeal 
collateral vessels of the left posterior cerebral artery filling 
retrogradely the territory of the left middle cerebral artery
Figure 3. Cerebral angiography revealed right internal 
carotid artery occlusion after the emergence of the anterior 
choroidal artery and an abnormal network of transdural 
collateral vessels that filled retrogradely the territory of the 
right middle and anterior cerebral arteries
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Although cerebral angiography is the gold standard for diagnosis of MMS, magnetic resonance imaging (MRI) can be used to detect blood 
flow disturbances associated with presymptomatic vascular lesions, as well as for a sensitive and quantitative analysis of the vascular 
changes[4, 5]. TCD provides a non-invasive method to evaluate intracranial haemodynamics and it has been used in the initial evaluation 
and to follow up progression of MMS. Disease severity and its angiographic progression is classified into the 6 stages of the Suzuki grading 
system[1].  
Treatment of acute stroke should include intravenous hydration, avoidance of hypotension and administration of supplemental oxygen to 
avoid hyperventilation and consequent vasoconstriction. Currently, secondary stroke prevention for patients with symptomatic MMS is 
based on improving blood flow to the affected cerebral hemisphere by surgical revascularization. Two methods for revascularization, direct 
and indirect, have been described, the latter being the preferred option in younger children[1]. Considering medical therapy, the benefit of 
antiplatelet agents is limited and equivocal and oral anticoagulants are not recommend for long-term treatment[1]. 
We report a case of MMS arising after radiotherapy 20 years previously for craniopharyngioma, emphasizing the importance of an appropriate 
understanding of late complications of cranial radio¬therapy for long-term patient follow-up. In addition to the strong association between 
radiotherapy for craniopharyngiomas and MMS, the characteristic angiographic pattern favoured the diagnosis of this condition in our 
patient. As MMS is usually progressive, early detection and prompt treatment of MMS are both mandatory, as the consequences of delayed 
treatment are disastrous in young patients, including cognitive and neurologic decline due to repeated strokes. 
